Research & Clinical Trials

Muscle health and beyond

A repeatable, MRI-based method for tracking muscle health, far beyond traditional body composition estimates.

Springbok quantifies individual muscle quality, fat infiltration, and symmetry, providing precise, actionable data at the individual muscle level.

Lower Extremity

Core

Full Body

Muscle Size

Asymmetry

Fat Infiltration

Tendons

Bone

Scar tissue

Built for research, trials, and scale

Objective data delivered with the precision, speed, and consistency modern trials and studies demand.

Reproducible Analysis

AI-driven segmentation ensures consistent, site-agnostic muscle-level analysis, minimizing manual variability.

Accelerated Time to Data

Access structured, high-fidelity muscle data within days, streamlining timelines for research and clinical workflows.

Sensitive Detection of Change

Detect nuanced shifts in volume, fat infiltration, and symmetry to track disease progression or therapeutic impact.

Regulatory Confidence

Compliant with FDA, GDPR, ISO, and SOC 2 standards to support use as a validated imaging endpoint.

For Researchers

High-Resolution Data for Scientific Impact

From biomechanics to disease modeling, Springbok delivers analysis-ready data fast, eliminating post-processing bottlenecks.

Faster Data, Smarter Insights

Eliminate post-processing bottlenecks. Go from scan to analysis in days to accelerate experimental cycles.

Longitudinal Tracking

Monitor regional or muscle-specific changes in aging, recovery, or pathology.

Reliable Segmentation

Precise delineation of muscles across imaging protocols, populations, and time points.

Collaboration-Ready

Export structured datasets with visual overlays and audit trails for reproducibility and multi-site research.

Request a proposal

For Clinical Trials

Validated Muscle Metrics to Strengthen Trial Design

Quantitative Endpoints

Deliver 3D metrics on individual muscle size, fat infiltration, asymmetry, and structural change with high fidelity.

Streamlined Trial Timelines

Automate MRI data processing to accelerate timelines
and simplify interim evaluations.

Multi-Site Compatible

Compatible with standard MRI protocols and vendor-agnostic, ensuring reproducibility at scale.

Compliance-Backed Confidence

FDA-cleared and aligned with global standards for submission-quality evidence.

Get set up

What is a Springbok scan?

A fast, non-invasive way to get validated muscle and MSK data from a single MRI.

Scan

10-45 minute MRI

Process

24 hours Processing time

Report

Results 2-3 days

When measuring muscle matters

Trusted across clinical trials, therapeutic research, and disease modeling

Springbok delivers high-resolution, MRI-based muscle health data used by pharmaceutical, biotech, and academic partners to accelerate development, refine trial design, and improve sensitivity to meaningful change.

FSHD & Neuromuscular Disease

Track disease progression at the individual muscle level and quantify therapeutic response in adult and pediatric cohorts. Capture subtle, heterogeneous changes over time to support endpoint development in rare disease trials.

Aging & Longevity Research

Detect early changes in muscle composition and monitor sarcopenia risk with anatomically precise, longitudinal data. Ideal for aging studies, lifestyle interventions, and vitality-focused programs.

Therapeutic Response Tracking

Assess structural muscle changes in response to GLP-1 therapies, anti-inflammatories, regenerative treatments, and metabolic interventions, using validated, repeatable imaging biomarkers.

Stratification & Trial Optimization

Use detailed muscle profiling to identify patient subgroups, refine eligibility criteria, and inform endpoint selection, improving consistency and sensitivity across trial arms.

Body Composition Analysis

Move beyond BMI and DXA. Springbok provides direct, MRI-based measurement of muscle volume, fat infiltration, and asymmetry, offering more clinically relevant, muscle-specific insight.

Disease Progression Modeling

Leverage longitudinal imaging to map progression pathways, predict functional decline, and validate early biomarkers across complex musculoskeletal and systemic conditions.

FDA 510(k) Clearance For MuscleView™

Validated. Scalable. Proven.

Backed by FDA-cleared technology, we deliver reliable, high-resolution muscle analysis across diverse populations and imaging environments.

Springbok is essential to our analytical pipeline as we process and critically assess the clinical trial data we are gathering in our efforts to reverse various aspects of aging. Springbok greatly enhances the accuracy and acuity of our outcomes, allowing us to more clearly understand how muscle and the body changes with IMMUNA over time.

Erin Curry

Immunis / Director of Medical Affairs

We are excited to expand the scope of our work with Springbok Analytics. This technology can benefit an FSHD-focused clinical trial by giving us new perspectives on what can be modulated by drug therapy. The shorter exam duration will improve patient tolerability and Springbok's comprehensive individual muscle analytics get us closer to deriving personalized progression models.

Dr. Seth Friedman, PhD

FSHD CTRN, Seattle Children’s / Lead Imaging Coordinator

FSHD Global is excited to support this innovative technology as we seek to revolutionize muscle analysis in the clinical trial and broader research fields to further understand disease progression and measure the effectiveness of future treatments.

Emma Weatherley

FSHD Global Research Foundation / Managing Director

High-quality, objective data is essential in early clinical development, especially when advancing a first-in-class therapeutic. Springbok’s automated muscle analysis gives us a detailed view of how EPI-321 may be impacting muscle tissue, strengthening our ability to assess early signals and shape future development.

Amber Salzman, Ph.D.

CEO, Epicrispr Biotechnologies

Trusted by: